Hemant Surgical Industries
- Market cap
- ₹ 829 Cr.
- P/E
- 49.3x
- P/B
- 5.68x
- 52-week range
- 215 – 679
- ROE
- 17%
- ROCE
- 19%
- Dividend yield
- 0%
- Debt / equity
- 0.36
- Sector
- Healthcare Equipment & Supplies
- Industry
- Medical Equipment & Supplies
- Listed on
- BSE SME
About
Hemant Surgical Industries Limited is an India-based company, which manufactures, imports, assembles and markets a comprehensive portfolio of medical equipment and disposables. Its product offerings cover a wide equipment and disposables required for renal care; cardiovascular disease; respiratory disease; critical care and radiology, and surgical disposables. Its wide range of products includes some of the indigenously manufactured products along with some other products that are imported from countries like Japan, China, France and Australia and are further processed in its assembly units. In addition, it also provides services for the maintenance and running of dialysis centers. Its product categories include JMS products, healthcare products, dialysis products, surgical disposable products, criticare products, radiology products, diabetic foot care products and ophthalmology products. Its JMS products include JMS Meditape, JMS Infusion Set, JMS Pediatric Infusion set, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Medical Equipment & Supplies: 25 companies →Hemant Surgical Industries against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)49.3 against a typical 28.7: pricier than most peers (1st = cheapest).19th of 25
- Sales growth+187.9% against a typical +21.5% from a year earlier.3rd of 18
- Profit growth+116.7% against a typical +13.4% from a year earlier.2nd of 16
- Share price, 3 months+55.4% against a typical −7.9%.1st of 23
- Size₹ 828.6 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).7th of 24
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 51 | 58 | 48 | 58 | 49 | 58 | 64 | 167 |
| Expenses | 47 | 52 | 44 | 51 | 45 | 52 | 57 | 151 |
| Operating Profit | 4 | 6 | 3 | 7 | 4 | 6 | 8 | 16 |
| OPM % | 8% | 11% | 7% | 13% | 7% | 10% | 12% | 9% |
| Other Income | 1 | 1 | 3 | 2 | 2 | 3 | 2 | 3 |
| Interest | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 4 | 6 | 5 | 8 | 4 | 6 | 7 | 16 |
| Tax % | 36% | 18% | 17% | 27% | 29% | 18% | 25% | 22% |
| Net Profit | 2 | 5 | 4 | 6 | 3 | 5 | 5 | 13 |
| EPS in Rs | 48.12 | 6.93 | 3.75 | 5.63 | 3.05 | 4.74 | 4.15 | 9.84 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 31%
- 3 Years
- 28%
- TTM
- 117%
- 10 Years
- —
- 5 Years
- 66%
- 3 Years
- 30%
- TTM
- 114%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 44%
- TTM
- —
- 10 Years
- —
- 5 Years
- 21%
- 3 Years
- 17%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Hemant Surgical Industries | ₹ 575.00 | ₹ 829 Cr. | 49.3x | 5.7x | 17% | — |
| Lenskart Solutions | ₹ 627.55 | ₹ 1,08,959 Cr. | 181x | 10.7x | 6.7% | 5.7% |
| Poly Medicure | ₹ 1,446.80 | ₹ 14,582 Cr. | 52.1x | 5.5x | 11% | 17.1% |
| Laxmi Dental | ₹ 171.25 | ₹ 946 Cr. | 35.6x | 5x | 12.8% | 9.5% |
| One Global Service Provider | ₹ 372.00 | ₹ 721 Cr. | 17x | 8.3x | 65.2% | 14% |
| Mallcom (India) | ₹ 909.00 | ₹ 567 Cr. | 21.9x | 2.1x | 9.7% | 5.6% |
Management
- Hanskumar Shamji Shah
- Chairman of the Board, Managing Director
- Kaushik Hanskumar Shah
- Chief Financial Officer, Whole Time Director
- Meenal Ajmera
- Compliance Officer, Company Secretary
- Hemant Praful Shah
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.